Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: OmniAb Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Contineum Therapeutics Inc. June 26, 202595.2%
-
OmniAb Inc. June 18, 202475.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Atrium Therapeutics Inc. | Shares withheld for tax | −126,418 | $8.95 | $1,131,441 |
| Jun 18, 2024 | OmniAb Inc. | Option exercise | +20,000 | — | — |
| Jan 30, 2023 | OmniAb Inc. | Grant or award | +8,753 | — | — |
Questions about Sarah Boyce
What boards is Sarah Boyce on?
Sarah Boyce sits on the boards of Atrium Therapeutics Inc., Contineum Therapeutics Inc. and OmniAb Inc.
How long has Sarah Boyce served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.